United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
22.70B
Market cap22.70B
Price-Earnings ratio
18.54
Price-Earnings ratio18.54
Dividend yield
Dividend yield
Average volume
564.68K
Average volume564.68K
High today
$535.77
High today$535.77
Low today
$522.04
Low today$522.04
Open price
$528.47
Open price$528.47
Volume
430.16K
Volume430.16K
52 Week high
$609.35
52 Week high$609.35
52 Week low
$302.19
52 Week low$302.19

Stock Snapshot

United Therapeutics(UTHR) stock is priced at $529.14, giving the company a market capitalization of 22.7B. It carries a P/E multiple of 18.54.

On 2026-08-19, United Therapeutics(UTHR) stock traded between a low of $522.04 and a high of $535.77. Shares are currently priced at $529.14, which is +1.4% above the low and -1.2% below the high.

The United Therapeutics(UTHR)'s current trading volume is 430.16K, compared to an average daily volume of 564.68K.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $609.35 and a 52-week low of $302.19.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $609.35 and a 52-week low of $302.19.

UTHR News

Simply Wall St 1d
United Therapeutics Could Be 24% Undervalued On TETON PPF Enrollment Progress - simplywall.st

...

United Therapeutics Could Be 24% Undervalued On TETON PPF Enrollment Progress - simplywall.st

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
18.8%
Sell
0%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.